APA (7th ed.) Citation

A, H., S, N., G, D., K, M., MD, M., R, A., . . . S, D. (2026). Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. United European gastroenterology journal, 14(4), e70214. https://doi.org/10.1002/ueg2.70214

Chicago Style (17th ed.) Citation

A, Hart, et al. "Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis." United European Gastroenterology Journal 14, no. 4 (2026): e70214. https://doi.org/10.1002/ueg2.70214.

MLA (9th ed.) Citation

A, Hart, et al. "Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis." United European Gastroenterology Journal, vol. 14, no. 4, 2026, p. e70214, https://doi.org/10.1002/ueg2.70214.